Risks of Substituting Epigenetic Age for Chronological Age in Medicine and Policy

Epigenetic clocks-statistical models that estimate biological age from DNA methylation patterns-are increasingly used or proposed for use in both biomedical and non-biomedical contexts. This article argues that the use of epigenetic clocks in these contexts introduces specific ethical problems. Three sets of problems are identified. The first concerns the measure itself: epigenetic age is a model-dependent estimate of a contested concept, and treating it as a policy target risks decoupling it from its intended outcomes. The second concerns its substitution for chronological age: biological testing introduces risks of temporal instability, differential accuracy across demographic groups, expanded inferential scope beyond what individuals have consented to have assessed, and unequal access to score-improving interventions. The third and deepest concern is structural inequity. Epigenetic clocks accurately capture the biological effects of social disadvantage, and policies that impose further burdens on structurally disadvantaged groups using epigenetic age risk entrenching that disadvantage under the guise of scientific objectivity. The analysis concludes that defensible use requires population-specific validation, transparency about inferential scope, and prior assessment of distributional effects on disadvantaged groups.

Authors

Institutions

Publication Details

Journal
Bioethics
Published
2026-11-17
DOI
https://doi.org/10.1111/bioe.70213
Primary Topic
Ethics and bioethics in healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Risks of Substituting Epigenetic Age for Chronological Age in Medicine and Policy

Nicolai Wohns
4 links
Bioethics
Ethics and bioethics in healthcare
article

Risks of Substituting Epigenetic Age for Chronological Age in Medicine and Policy

Nicolai Wohns
article en

Abstract

Epigenetic clocks-statistical models that estimate biological age from DNA methylation patterns-are increasingly used or proposed for use in both biomedical and non-biomedical contexts. This article argues that the use of epigenetic clocks in these contexts introduces specific ethical problems. Three sets of problems are identified. The first concerns the measure itself: epigenetic age is a model-dependent estimate of a contested concept, and treating it as a policy target risks decoupling it from its intended outcomes. The second concerns its substitution for chronological age: biological testing introduces risks of temporal instability, differential accuracy across demographic groups, expanded inferential scope beyond what individuals have consented to have assessed, and unequal access to score-improving interventions. The third and deepest concern is structural inequity. Epigenetic clocks accurately capture the biological effects of social disadvantage, and policies that impose further burdens on structurally disadvantaged groups using epigenetic age risk entrenching that disadvantage under the guise of scientific objectivity. The analysis concludes that defensible use requires population-specific validation, transparency about inferential scope, and prior assessment of distributional effects on disadvantaged groups.

Bioethics
University of Washington (US)
Reduced inequalities, Good health and well-being
Ethics and bioethics in healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon